Trump Halts $500M in mRNA Vaccine Funding, Cites Safety Concerns

Donald Trump's Health Secretary, Robert Kennedy Jr., announced the cessation of funding for mRNA vaccine research, totaling $500 million. The investments were intended for the development of vaccines against avian and swine flu, with recipients including pharmaceutical companies like Moderna, Pfizer, and Sanofi.

Mr. Kennedy questioned the effectiveness and safety of mRNA vaccines, arguing that they do not effectively protect against upper respiratory infections such as COVID and influenza. The funds will be redirected to 'safer' technologies. The funding was to be provided by BARDA.

This decision comes amid strong opposition from the scientific community, which considers mRNA technology successful and crucial for combating the COVID-19 pandemic.